Description
Statins are classified as HMG-CoA reductase inhibitors. They are recommended as the drug of choice for lipid-lowering therapy in patients at increased risks for cardiovascular diseases and stroke. HMG-CoA reductase is the rate-limiting step in cholesterol synthesis. By inhibiting this crucial step, statins reduce cholesterol in the liver.